Biomolecular imaging and diagnosis




The changes in GM1 ganglioside levels in patients affected by GM1 gangliosidosis can be followed by means of fluorescence microscopy and flow-cytometry, a useful approach that can be used also for the diagnosis and management of other lysosomal diseases.



Description

The group is devoted at applying advanced microscopy techniques and imaging approaches based on fluorescence to tackle the understanding, diagnosis and treatment of neurodegenerative and metabolic diseases. We are currently focused on three main objectives:
1. Studying the molecular basis of Alzheimer’s disease, in particular the influence of cholesterol and neuronal activity on the processing of the amyloid precursor protein.
2. Investigating the release from nanoparticles and diffusion of drugs by means of single molecule tracking within the context of nose to brain delivery of biopharmaceutics to treat Multiple Sclerosis.
3. Translating basic research methods to the clinical diagnosis of infantile metabolic neurodegenerative diseases, such as GM1 Gangliosidosis.


INO Staff

Calamai Martino (Contact Person)
Capitini Claudia
Cicchi Riccardo
Credi Caterina

gdpr-image
This site uses cookies. If you decide to continue browsing we consider that you accept their use. For more information about cookies and how to delete them please read our Info Policy on cookies use.
Read more